Press Releases
Get the latest news from Elanco and how we're shaping a future of Food and Companionship Enriching Life.
Our Press Releases
Explore our resources below to get a taste of life at Elanco and how we're driving innovation in animal health forward.
Keri McGrath | 01/20/2022
Elanco’s ZORBIUM™ (buprenorphine transdermal solution) - the first long-acting transdermal buprenorphine for cats - Gains U.S. Approval
Colleen Parr Dekker | 01/04/2022
Elanco to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Colleen Parr Dekker | 11/30/2021
Elanco Announces Changes to Simplify Organizational Structure, Drive Profitable Growth and Focus Investments on Growth and Innovation Opportunities
Colleen Parr Dekker | 11/16/2021
Elanco to Participate in the Evercore ISI 4th Annual HealthCONx Conference
Keri McGrath | 11/08/2021
Elanco Joins Newly-Formed Consortium Advancing Climate-Neutral Cattle Innovation
Colleen Parr Dekker | 11/05/2021
Elanco Animal Health Reports Third Quarter 2021 Results Exceeding Revenue Guidance; Raising Full Year 2021 Revenue Guidance
Tiffany Kanaga | 10/18/2021
Elanco Animal Health Selected for 2021 FORTUNE’s Change the World List
Tiffany Kanaga | 10/07/2021
Elanco Confirms Date and Conference Call for Third Quarter 2021 Financial Results Announcement
Contact Elanco
Questions? For all inquiries, contact Elanco Animal Health at 1-877-352-6261, and we'll be happy to help.
About Elanco
Learn why we're a leading provider of innovative solutions that protect and enhance animal health.
Read About Elanco Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2022 Elanco.